World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
99
Citations
37986
World Ranking
8560
National Ranking
22

Mical Paul publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Mical Paul sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 455 publications — 50th percentile

50% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Mical Paul D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Mical Paul sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 99 D-Index — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Mical Paul is affiliated with the Technion - Israel Institute of Technology in Israel. Their research spans primarily the fields of medicine and biochemistry, genetics, and molecular biology, with a significant focus on epidemiology, molecular medicine, infectious diseases, pharmacology, and applied microbiology and biotechnology.

The scientist's main topics of work encompass antibiotic resistance in bacteria, antibiotic use and resistance, antibiotics pharmacokinetics and efficacy, bacterial identification and susceptibility testing, antimicrobial resistance in Staphylococcus, pneumonia and respiratory infections, and health systems, economic evaluations, and quality of life.

Notable recent publications include:

  • European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European Society of Intensive Care Medicine), 2021, Clinical Microbiology and Infection
  • Long-term consequences of COVID-19: research needs, 2020, The Lancet Infectious Diseases
  • Critical analysis of antibacterial agents in clinical development, 2020, Nature Reviews Microbiology
  • Comparison of antibiotic-resistant bacteria and antibiotic resistance genes abundance in hospital and community wastewater: A systematic review, 2020, The Science of The Total Environment
  • Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia, 2020, JAMA

Frequent co-authors collaborating with Mical Paul include:

  • Dafna Yahav (51 co-publications)
  • Leonard Leibovici (39 co-publications)
  • Yehuda Carmeli (21 co-publications)
  • Jesús Rodríguez-Baño (20 co-publications)
  • George L. Daikos (19 co-publications)

The venues with the highest number of publications by this author are:

  • Clinical Microbiology and Infection (32 publications)
  • Open Forum Infectious Diseases (14 publications)
  • Clinical Infectious Diseases (8 publications)
  • Journal of Antimicrobial Chemotherapy (8 publications)
  • Research Square (5 publications)

Best Publications

  • Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis.

    Evelina Tacconelli;Elena Carrara;Alessia Savoldi;Stephan Harbarth

  • Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis

    Mical Paul;Vered Shani;Eli Muchtar;Galia Kariv

  • Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data.

    Stella G Muthuri;Sudhir Venkatesan;Puja R Myles;Jo Leonardi-Bee

  • Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial

    Mical Paul;Mical Paul;George L Daikos;Emanuele Durante-Mangoni;Dafna Yahav;Dafna Yahav

  • β lactam monotherapy versus β lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials

    Mical Paul;Ishay Benuri-Silbiger;Karla Soares-Weiser;Leonard Leibovici

  • Meta-analysis : Antibiotic prophylaxis reduces mortality in neutropenic patients

    Anat Gafter-Gvili;Abigail Fraser;Mical Paul;Leonard Leibovici

  • Prophylaxis for Pneumocystis pneumonia (PCP) in non‐HIV immunocompromised patients

    Anat Stern;Hefziba Green;Mical Paul;Liat Vidal

  • Beta lactam antibiotic monotherapy versus beta lactam‐aminoglycoside antibiotic combination therapy for sepsis

    Mical Paul;Adi Lador;Simona Grozinsky-Glasberg;Leonard Leibovici

  • Comparative meta-analysis of the effect of Lactobacillus species on weight gain in humans and animals

    Matthieu Million;Emmanouil Angelakis;Mical Paul;Fabrice Armougom

  • Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy

    Anat Gafter-Gvili;Abigail Fraser;Mical Paul;Liat Vidal

  • PCR Diagnosis of Invasive Candidiasis: Systematic Review and Meta-Analysis

    Tomer Avni;Leonard Leibovici;Mical Paul

  • Prophylaxis of Pneumocystis Pneumonia in Immunocompromised Non-HIV-Infected Patients: Systematic Review and Meta-analysis of Randomized Controlled Trials

    Hefziba Green;Mical Paul;Mical Paul;Liat Vidal;Liat Vidal;Leonard Leibovici;Leonard Leibovici

  • Antifungal Prophylaxis in Cancer Patients After Chemotherapy or Hematopoietic Stem-Cell Transplantation: Systematic Review and Meta-Analysis

    Eyal Robenshtok;Anat Gafter-Gvili;Elad Goldberg;Miriam Weinberger

  • Treatment of human brucellosis: systematic review and meta-analysis of randomised controlled trials.

    Keren Skalsky;Dafna Yahav;Jihad Bishara;Silvio Pitlik

  • Comparative Efficacy and Safety of Vancomycin versus Teicoplanin: Systematic Review and Meta-Analysis

    Shuli Svetitsky;Leonard Leibovici;Mical Paul

  • Long-term consequences of COVID-19: research needs.

    Dana Yelin;Eytan Wirtheim;Pauline Vetter;Andre C Kalil

  • Colistin: new lessons on an old antibiotic

    D. Yahav;D. Yahav;L. Farbman;L. Farbman;L. Leibovici;L. Leibovici;M. Paul;M. Paul

  • Efficacy and safety of cefepime: a systematic review and meta-analysis

    Dafna Yahav;Mical Paul;Mical Paul;Abigail Fraser;Abigail Fraser;Nadav Sarid;Nadav Sarid

  • Efficacy and safety of tigecycline: a systematic review and meta-analysis

    Dafna Yahav;Adi Lador;Adi Lador;Mical Paul;Mical Paul;Leonard Leibovici;Leonard Leibovici

  • β lactam monotherapy versus β lactam-aminoglycoside combination therapy for fever with neutropenia: systematic review and meta-analysis

    Mical Paul;Karla Soares-Weiser;Leonard Leibovici

Frequent Co-Authors

Leonard Leibovici
Leonard Leibovici Tel Aviv University
Roberto Cauda
Roberto Cauda Catholic University of the Sacred Heart
Jesús Rodríguez-Baño
Jesús Rodríguez-Baño University of Seville
Cristina Mussini
Cristina Mussini University of Modena and Reggio Emilia
Waleria Hryniewicz
Waleria Hryniewicz Narodowy Instytut Leków
Marek Gniadkowski
Marek Gniadkowski Medical University of Warsaw
Herman Goossens
Herman Goossens University of Antwerp
Yehuda Carmeli
Yehuda Carmeli Tel Aviv University
Surbhi Malhotra-Kumar
Surbhi Malhotra-Kumar University of Antwerp
David L. Paterson
David L. Paterson University of Queensland

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a future in medicine, a variety of online healthcare degrees can help you broaden your career options and specialize in high-demand fields. Many students are seeking online mha programs affordable in order to move into healthcare management roles without taking on excessive debt.

Advanced practitioners, such as nurse leaders, are pursuing further credentials through the best online dnp programs for the flexibility to balance ongoing work with their studies.

For those interested in pharmaceutical careers, it’s important to consider the steady rise in online pharmacy school cost and look for reputable, cost-efficient pathways.

Additionally, specialized roles in digital health are growing rapidly. Students exploring health data careers should investigate rhit programs online to become experts in managing electronic health information, improving both patient care and organizational efficiency.

Each of these online degrees opens new doors in the dynamic healthcare industry, while offering the flexibility and affordability needed by today’s aspiring professionals.

Best Scientists Citing Mical Paul

Trending Scientists

Recently Published Articles